A critical discovery in cancer investigation is emerging with the use of mini-antibodies to re-engage mutated p53. This vital malignant suppressor protein is frequently disabled in many kinds of malignancies, leading https://bookmarkprobe.com/story22224605/mini-antibodies-reactivate-p53-the-promising-approach-for-tumor-treatment